Kim Hyeong Mi, An Hyo Sun, Bae Jung-Soo, Kim Jung Yun, Choi Chi Ho, Kim Ju Yeon, Lim Joo Hyuck, Choi Joon-Hun, Song Hyunnam, Moon Sung Ho, Park Young Jun, Chang Shin-Jae, Choi Sun Young
Biotechnology Research Institute, R&D Division, Celltrion, Inc., Incheon, Republic of Korea.
Celltrion Chemical Research Institute, Yongin, Republic of Korea.
Arch Dermatol Res. 2017 Jul;309(5):397-402. doi: 10.1007/s00403-017-1731-6. Epub 2017 Mar 16.
Wrinkle formation and abnormal pigmentation are major clinical alterations associated with skin aging. As the aim of our study was to investigate the effects of palmitoyl-KVK-L-ascorbic acid on skin aging, the anti-wrinkle and depigmentation effects of palmitoyl-KVK-L-ascorbic acid were evaluated by measuring collagen expression in dermal fibroblast cells and inhibition of melanogenesis in B16F1 cells, respectively. The anti-aging effect of palmitoyl-KVK-L-ascorbic acid cream was also evaluated against a placebo cream in a clinical trial. Our results confirmed that the expression of type Ι collagen in dermal fibroblast cells treated with palmitoyl-KVK-L-ascorbic acid (0.1-4 μg/mL) increased in a dose-dependent manner. In B16F1 cells, treatment with 20 μg/mL palmitoyl-KVK-L-ascorbic acid reduced the melanin content by approximately 20% compared to alpha-melanocyte stimulating hormone treatment. In the clinical trial, application of palmitoyl-KVK-L-ascorbic acid cream led to an improvement in skin roughness and lightness in 12 and 8 weeks, respectively. Our data show that palmitoyl-KVK-L-ascorbic acid is an effective anti-aging agent that reduces wrinkles and abnormal skin pigmentation.
皱纹形成和色素沉着异常是与皮肤老化相关的主要临床变化。由于我们的研究目的是调查棕榈酰-KVK-L-抗坏血酸对皮肤老化的影响,因此分别通过测量真皮成纤维细胞中的胶原蛋白表达和B16F1细胞中黑色素生成的抑制情况,来评估棕榈酰-KVK-L-抗坏血酸的抗皱和美白效果。在一项临床试验中,还针对安慰剂乳膏评估了棕榈酰-KVK-L-抗坏血酸乳膏的抗老化效果。我们的结果证实,用棕榈酰-KVK-L-抗坏血酸(0.1-4μg/mL)处理的真皮成纤维细胞中Ⅰ型胶原蛋白的表达呈剂量依赖性增加。在B16F1细胞中,与α-黑素细胞刺激素处理相比,用20μg/mL棕榈酰-KVK-L-抗坏血酸处理使黑色素含量降低了约20%。在临床试验中,使用棕榈酰-KVK-L-抗坏血酸乳膏分别在12周和8周时使皮肤粗糙度和亮度得到改善。我们的数据表明,棕榈酰-KVK-L-抗坏血酸是一种有效的抗老化剂,可减少皱纹和皮肤色素沉着异常。